Cardiac specific differentiation of mouse embryonic stem cells.
Embryonic stem (ES) cells may represent an alternative source of functionally intact cardiomyocytes for the causal treatment of cardiovascular diseases. However, this requires cardiac-specific differentiation of stem cells and the selection of pure lineages consisting of early embryonic cardiomyocytes. Therefore, an understanding of the basic mechanisms of heart development is essential for selective differentiation of embryonic stem cells into cardiac cells. The development of cardiac cells from embryonic stem cells is regulated by several soluble factors and signalling molecules together with cardiac specific transcription factors such as the zinc-finger GATA proteins and Nkx-2.5. GATA-4 and Nkx-2.5 seem to be essential for heart development. The use of enhanced green fluorescent protein (EGFP) under the control of cardiac-specific promoters in combination with the ES cell system has allowed for the functional characterisation of cardiac precursor cells. Embryonic stem cell-derived cardiomyocytes developmentally express similar cardiac-specific proteins, ion channels and signalling molecules to that of adult cardiomyocytes. Furthermore, identification of growth factors and signalling molecules under cell culture conditions is crucial for the selective cardiac differentiation of embryonic stem cells. Therefore, serum-free culture conditions have to be established in order to examine the influence of different growth factors and signalling molecules on cardiac development and/or formation from ES cells. Although significant progress has been made in generating cardiac cell lineage by the combination of genetically manipulative methods with selective culture conditions for cell transplantation therapy, one of the remaining future challenges for transplantation in humans is the immunological rejection of the engrafted cardiomyocytes.
Sachinidis
Agapios
A
Center of Physiology and Pathophysiology, Department of Neurophysiology, University of Cologne, Robert-Koch-Strasse 39, D-50931, Cologne, Germany. a.sachinidis@uni-koeln.de
Fleischmann
Bernd K
BK
Kolossov
Eugen
E
Wartenberg
Maria
M
Sauer
Heinrich
H
Hescheler
Jürgen
J
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D009202:Cardiomyopathies / Q000601:surgery; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation; D004627:Embryonic Induction / Q000502:physiology*; D006084:Graft Rejection / Q000517:prevention & control; D006133:Growth Substances / Q000502:physiology; D006321:Heart / Q000196:embryology*; D051379:Mice; D032386:Myoblasts, Cardiac / Q000166:cytology; D009569:Nitric Oxide / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D026362:Serum Response Factor / Q000378:metabolism; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology*; D014157:Transcription Factors / Q000378:metabolism; D016212:Transforming Growth Factor beta; D051153:Wnt Proteins; D029961:Zebrafish Proteins
C525718:BMP2 protein, human; C525719:Bmp2 protein, mouse; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D006133:Growth Substances; D011518:Proto-Oncogene Proteins; D017382:Reactive Oxygen Species; D026362:Serum Response Factor; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D051153:Wnt Proteins; D029961:Zebrafish Proteins; D009569:Nitric Oxide; D019869:Phosphatidylinositol 3-Kinases